Relationship of Insulin Resistance to Prevalence and Progression of Coronary Artery Calcification Beyond Metabolic Syndrome Components: Shiga Epidemiological Study of Subclinical Atherosclerosis
The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
Objective—: The association between insulin resistance (IR) and coronary artery calcification (CAC) has been uncertain after adjustment for metabolic syndrome components. We aimed to evaluate whether IR is associated with CAC prevalence or progression independently of metabolic syndrome components. Approach and Results—: We conducted a population-based study in a random sample of Japanese men aged 40 to 79 years and determined IR using the homeostasis model assessment of insulin resistance (HOMA-IR). The associations of HOMA-IR and other diabetic parameters per 1-SD increase with CAC prevalence and progression were evaluated using multivariable logistic regression. Of 1006 total participants at baseline (mean age, 64±10 years), CAC prevalence was observed in 646 (64.2%), and of 789 participants at follow-up (mean duration, 4.9±1.3 years), CAC progression was observed in 365 (46.3%). After adjustment for covariates including metabolic syndrome components, higher HOMA-IR was independently associated with CAC prevalence (adjusted odds ratio 1.34, 95% confidence interval 1.10–1.63; P =0.003) and progression (odds ratio 1.32, 95% confidence interval 1.09–1.60; P =0.004). In participants without diabetes mellitus, positive associations were similarly observed (prevalence: odds ratio 1.29, 95% confidence interval 1.04–1.60; P =0.022; and progression: odds ratio 1.25, 95% confidence interval 1.01–1.55; P =0.042), whereas glucose and hemoglobin A1c were not associated with CAC prevalence and progression. Conclusions—: Higher IR was associated with CAC prevalence and progression independently of metabolic syndrome components in Japanese men and also in those without diabetes mellitus. Among diabetic measures, IR and fasting insulin, but not glucose and hemoglobin A1c, predicted CAC progression in men without diabetes mellitus.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Emerging Risk Factors Collaboration (2010) · The Lancet · doi:10.1016/s0140-6736(10)60484-9 · Cited by 5,125
Kronmal, R. A., McClelland, R. L., Detrano, R., Shea, S., Lima, J. A., Cushman, M., Bild, D. E., & Burke, G. L. (2007) · Circulation · doi:10.1161/circulationaha.106.674143 · Cited by 560
Progression of Coronary Calcium and Incident Coronary Heart Disease Events
Budoff, M. J., Young, R., Lopez, V. A., Kronmal, R. A., Nasir, K., Blumenthal, R. S., Detrano, R. C., Bild, D. E., Guerci, A. D., Liu, K., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.12.035 · Cited by 422
Gast, K. B., Tjeerdema, N., Stijnen, T., Smit, J. W. A., & Dekkers, O. M. (2012) · PLoS ONE · doi:10.1371/journal.pone.0052036 · Cited by 403 · cited 1×
“One previous meta-analysis described that the relative risk of CHD per 1-SD increase in HOMA-IR was higher than that in fasting insulin concentration.(21) However, this report compared insulin and HOMA-IR derived from different cohort studies and nested case–control studies, and therefore, we Table 1.”
ResultReilly, M. P., Wolfe, M. L., Rhodes, T., Girman, C., Mehta, N., & Rader, D. J. (2004) · Circulation · doi:10.1161/01.cir.0000138740.84883.9c · Cited by 185
Progression of Subclinical Coronary Atherosclerosis: Does Obesity Make a Difference?
Cassidy, A. E., Bielak, L. F., Zhou, Y., Sheedy, P. F., Turner, S. T., Breen, J. F., Araoz, P. A., Kullo, I. J., Lin, X., & Peyser, P. A. (2005) · Circulation · doi:10.1161/01.cir.0000161820.40494.5d · Cited by 114
Cited by
Cardiovascular consequences of metabolic syndrome
Tune, J. D., Goodwill, A. G., Sassoon, D. J., & Mather, K. J. (2017) · Translational Research · doi:10.1016/j.trsl.2017.01.001 · Cited by 568
Insulin Resistance and Atherosclerosis: Implications for Insulin-Sensitizing Agents
Di Pino, A., & DeFronzo, R. A. (2019) · Endocrine Reviews · doi:10.1210/er.2018-00141 · Cited by 535
Elevated TyG Index Predicts Progression of Coronary Artery Calcification
Park, K., Ahn, C. W., Lee, S. B., Kang, S., Nam, J. S., Lee, B. K., Kim, J. H., & Park, J. S. (2019) · Diabetes Care · doi:10.2337/dc18-1920 · Cited by 392
Yun, J.-S., & Ko, S.-H. (2021) · Metabolism · doi:10.1016/j.metabol.2021.154838 · Cited by 292
Highlighting Diabetes Mellitus: The Epidemic Continues
Schmidt, A. M. (2018) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.117.310221 · Cited by 292
Metadata
- Authors
- Yamazoe, M., Hisamatsu, T., Miura, K., Kadowaki, S., Zaid, M., Kadota, A., Torii, S., Miyazawa, I., Fujiyoshi, A., Arima, H., Sekikawa, A., Maegawa, H., Horie, M., & Ueshima, H.
- Venue
- Arteriosclerosis, Thrombosis, and Vascular Biology
- Published
- 2016-08
- Volume
- 36
- Issue
- 8
- Pages
- 1703-1708
- ISSN
- 1079-5642 (ISSN-L)
- 1524-4636
- OpenAlex
- W2413350242
- Cited by
- 59
- References
- 6
- FWCI
- 4.91
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.